Dr Jan Petracek of PharmInvent teaches at the upcoming 2-day course organized by the INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE in Berlin. His lectures will be devoted to the following three topics: Efficacy and Effectiveness Specification, Risk Minimisation, Benefit Optimisation. The IsoP course... |more|
On 11 June Dr. Jan Petracek will give a lecture on the Medication Errors: Definitions, Assessment and Consequences for Pharmacovigilance Practice. The 2-day course focuses on the new EU post-licensing legislation and is organized by INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE in Berlin. For details... |more|
DIA in cooperation with PharmInvent organises a EudraVigilance Training - Electronic Reporting of ICSRs in the EEA. This is the only training programme officially recognised by the European Medicines Agency. Participants that pass the competency assessment following the course will receive a... |more|
This course is fully booked! DIA in cooperation with PharmInvent organises a two day training course including hands-on exercises for personnel of marketing authorisation holders, consultants and other organisations, who are responsible for the electronic submission and maintenance of... |more|
On 24 April 2012, Dr. Martin Votava will give a lecture on Registration of Biosimilar Products in the European Union at the BioForum – the biggest and the most important international event for biotechnology in the region of Central Europe. BioForum will be held on 23-24th May in Brno, Czech... |more|
Dr Jan Petracek of PharmInvent teaches at the upcoming 3-day DIA course in EU pharmacovigilance. The course takes place in Berlin, 21-23 May, 2012. The Practical Guide for Pharmacovigilance: Clinical Trials and Post-Marketing is intended for individuals from the pharmaceutical industry,... |more|
Dr Martin Votava of PharmInvent has been invited to China to present the EMA Guideline on Signal Detection and New EU Initiatives at the DIA 4th Annual China Meeting: Collaboration and Innovation in China. The event will take place in Shanghai on May 21-23, 2012. |more|
On May 24-25, 2012 Dr Jan Petracek of PharmInvent will lecture at the DIA Benefit/Risk Management Training Course. The meeting will be held in the Courtyard Munich City Center, Munich, Germany. |more|
Dr. Jan Petracek of PharmInvent has been invited to work in the Program Committee of DIA EuroMeeting 2013 in the role of the Theme Leader for Pharmacovigilance and Risk Management. Together with co-leader Vicki Edwards (Abbott) he is preparing the call for abstracts and will be selecting the... |more|
PharmInvent is a well establihed company providing specialised services in areas of pharmacovigilance, regulatory affairs and drug development. We cover small molecules, as well as biologics and advanced therapies. We assist in centralized, mutual recognition, decentralized and national procedures for all legal bases of marketing authorisation applications.
You can find big pharma as well as small companies among our customers. Although we are particularly strong in the EU regulatory environment, we can provide our services globally. You can benefit from our unique expertise and insight into the European Medicines Agency, CHMP, CMDh as well as key national authorities in Europe.
PharmInvent is led by European ex-regulators with over 50 years of cumulative experience in pharmacovigilance and regulatory affairs. We pay high attention to the quality; our Quality Management System meets requirements of ISO 9001:2008. We meet SME criteria and are established in the European Union with headquarters in Prague, Czech Republic.
Tel: +420 774 497 884,
+420 774 497 885 
(c) 2010 - 2012 European Pharminvent Services, s.r.o. | Webdesign MHServis.cz